Maiwei Biotech-B (02493) intends to apply for the registration and issuance of targeted debt financing instruments with a scale not exceeding 1 billion yuan.
Miwei Biological-B (02493) released an announcement to further optimize its debt structure, broaden the company's financing channels, and reduce the company's financial costs. According to the company's strategic development plan and funding needs, the company intends to apply to the China Interbank Market Dealers Association to register and issue targeted debt financing instruments with a scale not exceeding 1 billion yuan (including 1 billion yuan).
Maiwei Biotechnology-B (02493) announced that, in order to further optimize the debt structure, broaden the company's financing channels, and reduce the company's financial costs, according to the company's strategic development plan and funding needs, the company intends to apply to the Bank of China Interbank Market Trader Association for registration to issue targeted debt financing instruments with a scale not exceeding 1 billion yuan (including 1 billion yuan).
Related Articles
GOLDENPOWER (03919) plans to discount approximately 14.29% of the issuance of 6.48 million shares, netting approximately HK$7.7 million.
US Stock Market Move | Nasdaq continues to hit new highs, star tech stocks are up. NVIDIA Corporation (NVDA.US) rose over 4%.
Lumentum (LITE.US) faces increasing supply-demand gap for its products. Several institutions are bullish on the growth driven by AI optical communication demand.
GOLDENPOWER (03919) plans to discount approximately 14.29% of the issuance of 6.48 million shares, netting approximately HK$7.7 million.
US Stock Market Move | Nasdaq continues to hit new highs, star tech stocks are up. NVIDIA Corporation (NVDA.US) rose over 4%.
Lumentum (LITE.US) faces increasing supply-demand gap for its products. Several institutions are bullish on the growth driven by AI optical communication demand.
